Schulke Octenisan Antimicrobial Wash Lotion 500ML

Product Information

MHRA: Drug Safety Update (May 19) Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy

Note: May 2012 - concentration and diluent used for arterial line patency has changed - see monograph below. LTHT QC approved product: Diuril 250mg/5mL oral suspension; manufacturer: Perrigo, USA; LTHT QC reference: QA1502001 MHRA: Drug Safety Update(Dec 20): Erythromycin: caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxabanMHRA: Drug Safety Update(May 2021):Levothyroxine: new prescribing advice for patients who experience symptoms on switching between different levothyroxine products

Drug Safety Update (Nov 18) Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction MHRA Drug Safety Update (Oct 18): Transdermal fentanyl patches: life-threatening and fatal opioid toxicity from accidental exposure, particularly in children Whilst using Octenisan Wash Lotion 150ml or Octenisan Wash Lotion 500ml there are other things you can do to prevent contracting MRSA, these include:IV dose and administration: prescribing and administration monograph for NEONATES on the NEONATAL unit